JASPER THERAPEUTICS INC

Jasper Therapeutics COO’s $0.75 buy of 881 non‑voting convertible preferred shares shows top‑level confidence, hinting at future conversion and potential upside for investors.

Jasper Therapeutics insider buys options & preferred stock amid Kira merger, signaling confidence and potential upside for long‑term investors.